GlassScriptPhysician profile
Peter A Symington
NPI 1629064837
$8,834.74
in general payments reported to CMS, 2019-2025
50 companies · $2,566 in 2025
The $2,566 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $407 · 2021: $943 · 2022: $1,410 · 2023: $1,649 · 2024: $1,366 · 2025: $2,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,565 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,564.87 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,377.06 | 2021-2025 | Vraylar |
| Amgen INC. | $1,496.43 | 2019-2025 | Otezla, Repatha, Otezla |
| Novo Nordisk INC | $1,046.76 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Boston Scientific Corporation | $409.52 | 2019-2023 | Watchman Flx |
| Incyte Corporation | $359.76 | 2024-2025 | Opzelura, Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.50 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $346.08 | 2022-2025 | Arexvy, Shingrix |
| Medtronic, INC. | $201.81 | 2023-2025 | Symplicity G3, Minimed 780g |
| Lundbeck LLC | $172.70 | 2024-2025 | Rexulti |
| Lilly USA, LLC | $168.71 | 2020-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $154.65 | 2020-2025 | |
| Allergan, INC. | $125.16 | 2020 | |
| Axonics, INC. | $120.65 | 2022 | |
| Redhill Biopharma INC. | $108.57 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $97.71 | 2019-2021 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Symington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.